Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 4

Boston Scientific Corp.

BSXNYSEEQUITYCurrent

SEC Filing

Filed Aug 7, 2026Accepted Aug 7, 2026, 4:16 PM EDTCIK 885725Accession 0001225208-26-007031
Share

Company context

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at

Current securities

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 23, 2026
  2. Material Cybersecurity IncidentsSep 8, 2026
  3. 4 filingSep 3, 2026
  4. Other EventsAug 26, 2026
  5. 4 filingAug 11, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗